Form 4: ProKidney Corp. Executive Darin J. Weber Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Darin J. Weber, Chief Regulatory Officer of ProKidney Corp., sold 17,238 Class A Ordinary Shares on May 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 20, 2024, Darin J. Weber, the Chief Regulatory Officer of ProKidney Corp., sold 17,238 Class A Ordinary Shares.
- The sale was executed automatically under a Rule 10b5-1 trading plan adopted on November 20, 2023.
- The shares were sold at a weighted average price of $4.0832, with individual transaction prices ranging from $3.74 to $4.44.
- Following the transaction, Weber directly owns 137,956 Class A Ordinary Shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an executive's stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 11/20/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 05/20/2024 | Date of the transaction (sale of shares) |
| 05/22/2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.